Page last updated: 2024-10-17

lactic acid and Mucopolysaccharidosis I

lactic acid has been researched along with Mucopolysaccharidosis I in 1 studies

Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.

Mucopolysaccharidosis I: Systemic lysosomal storage disease caused by a deficiency of alpha-L-iduronidase (IDURONIDASE) and characterized by progressive physical deterioration with urinary excretion of DERMATAN SULFATE and HEPARAN SULFATE. There are three recognized phenotypes representing a spectrum of clinical severity from severe to mild: Hurler syndrome, Hurler-Scheie syndrome and Scheie syndrome (formerly mucopolysaccharidosis V). Symptoms may include DWARFISM; hepatosplenomegaly; thick, coarse facial features with low nasal bridge; corneal clouding; cardiac complications; and noisy breathing.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salvalaio, M1
Rigon, L1
Belletti, D1
D'Avanzo, F1
Pederzoli, F1
Ruozi, B1
Marin, O1
Vandelli, MA1
Forni, F1
Scarpa, M1
Tomanin, R1
Tosi, G1

Other Studies

1 other study available for lactic acid and Mucopolysaccharidosis I

ArticleYear
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders.
    PloS one, 2016, Volume: 11, Issue:5

    Topics: Albumins; Animals; Blood-Brain Barrier; Disease Models, Animal; Drug Carriers; Enzyme Replacement Th

2016